NASDAQ$RPTX

Repare Therapeutics Inc · Q4 2025 earnings

Q4 2025 earnings · · Before market open · Investor relations

Reports awaiting report

Repare Therapeutics hasn't published Q4 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q3 2025

    Revenue
    $2.6M
    EPS
    $0.08
  • Year-ago · Q4 2024

    Q4 2024

    Revenue
    $0.00
    EPS
    -$0.67
  • FY2025 consensus

    Analyst consensus

    Revenue
    $7.83M
    EPS
    -$2.69

Revenue & EPS history

Repare Therapeutics · Revenue · Quarterly

$2.6M

Q3 2025
Beat estimate in 6 of 16 quarters(38%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 7 quarterly earnings reports

Historical avg

+0.7%

Avg return

Earnings day

+3.3%

Avg return

5 days after

-0.1%

Avg return

30 days after

55%

12 / 22 earnings

Positive

+19.7%

Q2 2023

Best reaction

-13.5%

Q4 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025-2.4%+27.5%+26.3%
Q2 2025+0.0%+3.3%+11.2%
Q1 2025+3.8%+0.0%+9.1%
Q4 2024-1.7%+0.9%-9.4%
Q3 2024-0.6%-4.4%-13.5%
Q2 2024-4.8%-8.3%-11.9%
Q1 2024+11.5%+7.7%+17.4%
Q4 2023+4.4%-0.6%-29.9%
Q3 2023-6.6%
Q2 2023+19.7%
Q1 2023+1.5%
Q4 2022+2.0%
Q3 2022+7.7%
Q2 2022+0.2%
Q1 2022-9.2%
Q4 2021+0.4%
Q3 2021+2.2%
Q2 2021-0.2%
Q1 2021+0.5%
Q4 2020-13.5%
Q3 2020-2.3%
Q2 2020+2.6%
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro